Until two years ago, only two classes of smoking cessation drugs were available: nicotine replacement therapy (NRT) with multiple delivery methods (gum, patch, inhaler, spray, lozenge) and the mild antidepressant bupropion. All approximately double the rate of cessation when compared to placebo. Chantix (Varenicline) is the first new agent for... Read more
Many smokers have misperceptions about nicotine, which
often result in not using evidence-based treatments when quitting.
Misperceptions about nicotine are often derived from how the harmful effects of
tobacco are presented in cessation materials. The following are key points to keep in mind when considering the use of
Nicotine... Read more
The existing smoking prevalence has
not significantly decreased in this country since 2004, demonstrating a stall
in the previous seven-year decline. That so many are still smoking given the
known dangers and the efficacious treatments available is a testament to the
power of tobacco addiction and a strong signal that tobacco cessation... Read more
It was with immense pleasure that I recently accepted the invitation to join HealthCentral as a Tobacco Treatment expert. As a nurse who has specialized in tobacco cessation for over 20 years, I am extremely passionate about doing all that is humanly possible to ensure that efficacious, evidence based cessation intervention for all tobacco... Read more